Allergic rhinitis decisions — 2025

The Board denied service connection for kidney disease, fatty liver disease, maxillary sinusitis, and allergic rhinitis. The claim for an immune disorder was remanded.

The Board denied service connection for sinusitis and rhinitis as the Veteran does not have a diagnosis or recurring symptoms of these conditions.

The Board granted an effective date of July 30, 2022 for the award of a 50 percent rating for generalized anxiety disorder and major depressive disorder (psychiatric disorder) but denied earlier effective dates for other conditions.

The Board granted service connection for right knee disability, including strain and osteoarthritis, but denied an evaluation in excess of 10 percent disabling for allergic rhinitis.

The Board remands the issue of a compensable disability rating for the Veteran's service-connected allergic rhinitis due to an inadequate VA examination.

The Board reinstated a separate rating of 10 percent for the Veteran's perforated nasal septum with chronic epistaxis and granted a separate 10 percent rating for vertigo/lightheadedness associated with it, while denying a higher rating for the perforated nasal septum and a separate rating for difficulty breathing.

The Board denied the Veteran's claim for service connection for sinusitis due to a lack of evidence supporting a current diagnosis. The claim for rhinitis was remanded for further medical evaluation.

The Board granted service connection for rhinitis, sinusitis, and obstructive sleep apnea (secondary to now service-connected rhinitis) based on the evidence of record.

The Board granted service connection for allergic rhinitis, effective August 5, 2021.

The Board denied service connection for TBI, RLE radicular pain, sinusitis, and an increased rating for PTSD. The claims for service connection for DM II, ED, headaches, left thumb disability and scar, right thumb, increased ratings for rhinitis, IBS with GERD, and OSA with bronchitis were remanded.

The appeal pertaining to the issue of entitlement to an effective date prior to August 26, 2010, for the award of service connection for allergic rhinitis is dismissed.

The Board denied an initial compensable rating for irritable bowel syndrome prior to October 29, 2020, and an earlier effective date for the grant of service connection for allergic rhinitis. The decision also remanded several issues related to left knee disability, left knee scars, and sinusitis.

The Veteran withdrew appeals for service connection of multiple conditions, resulting in the dismissal of all claims.

The Board granted service connection for skin cancer, type II diabetes mellitus, hypertension, allergic rhinitis, and chronic sinusitis based on presumptive exposure to herbicides. Peripheral neuropathy of the right and left lower extremities was also granted due to their relationship with the Veteran's service-connected diabetes.

The veteran withdrew his appeal for all issues, including initial and increased ratings for various conditions and service connection claims.

The Board denied service connection for various conditions, including dental trauma, chronic respiratory failure, headaches, allergic rhinitis and sinusitis, low back disability, left ankle disability, right ankle disability, hemorrhoids, epigastric pain, thyroid disability, monoclonal paraproteinemia, and hip disabilities.

The Board granted service connection for a sinus disability, to include rhinitis and sinusitis, based on the Veteran's lay statements regarding the onset of symptoms in service and their continuity since then.

The Board granted service connection for a right ankle condition, left ankle condition, bilateral foot condition, and allergic rhinitis. The claim for migraines was remanded.

The Board granted service connection for allergic rhinitis and prostate cancer under the PACT Act, but remanded claims for a right wrist disability and left achilles disability for further development.

The Board remands the claims for service connection for various conditions to correct duty-to-assist errors and obtain additional evidence.